
Vetoquinol Investor Relations Material
Latest events

Q1 2025 TU
24 Apr, 2025

H2 2024
20 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Vetoquinol SA
Access all reports
Vetoquinol SA is a French veterinary pharmaceutical company that focuses on the development, production, and marketing of veterinary drugs and non-medicinal products. The company provides a diverse range of products aimed at improving the health of companion animals, such as dogs and cats, as well as livestock including cattle and pigs. Vetoquinol's product offerings cover various therapy areas like pain management, mobility, inflammation, dermatology, udder health, anti-parasite solutions, and cardiology among others. The company is headquartered in Lure, France, and its shares are listed on the Euronext Paris.
Key slides for Vetoquinol SA


H1 2024
Vetoquinol SA


H1 2024
Vetoquinol SA
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
VETO
Country
🇫🇷 France